Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Celgene reports dual TNF/PDE inhibitors

April 17, 1997

Defibrillators associated with reduced mortality compared to antiarrhythmic drugs

April 17, 1997

Potent and selective ETA antagonist from SKB

April 16, 1997

CVT-124 enters phase II trials for CHF

April 16, 1997

Meiji Seika discloses new cardiotonic agents

April 16, 1997

Takeda reveals endothelin antagonists

April 14, 1997

FR-138104: a new D2 antagonist from Fujisawa

April 10, 1997

Lederle (Japan) reports novel cardioprotective agents

April 10, 1997

SmithKline Beecham claims novel endothelin antagonists

April 9, 1997

AMBI's Cardia Salt Alternative associated with reduced blood pressure

April 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...